DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 05 · Volume 52 · May 2014 DOI: 10.1055/s-004-26992


47. Jahrestagung und 25. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH)
Villach, 12. – 14. Juni 2014

Kongresspräsidenten: Univ.-Prof. Dr. Wolfgang Petritsch, Prim. Dr. Franz Siebert
Abstracts (HTML) List of Authors
  • P39
    Wagner, A; Mayr, C; Bach, D; Illig, R; Plaetzer, K; Berr, F; Pichler, M; Neureiter, D; Kiesslich, T:

    MicroRNA expression and photodynamic therapy in biliary tract cancer cell lines

  • P40
    Scheiner, B; Mandorfer, M; Payer, BA; Breitenecker, F; Aichelburg, MC; Grabmeier-Pfistershammer, K; Rieger, A; Trauner, M; Peck-Radosavljevic, M; Reiberger, T:

    Gesundheitsbezogene Lebensqualität bei HIV-HCV-Koinfektion vor, während und nach antiviraler Therapie mit PEGIFN + RBV

  • P41
    Pfisterer, N; Mandorfer, M; Schwabl, P; Summereder, C; Bucsics, T; Bota, S; Ferlitsch, A; Sieghart, W; Trauner, M; Peck-Radosavljevic, M:

    Die Behandlung mit Protonenpumpenhemmern ist weder mit der Entstehung einer spontan bakteriellen Peritonitis noch mit der Mortalität bei Patienten mit Leberzirrhose und Aszites assoziiert

  • P42
    Riedl, F; Schwabl, P; Payer, B; Schubert, T; Wagner, M; Garnys, L; Schiefer, A; Peck-Radosavljevic, M; Reiberger, T:

    The influence of splenectomy on hemodynamic and hematological abnormalities in cirrhotic and non-cirrhotic portal hypertensive rats

  • P43
    Bota, S; Mandorfer, M; Schwabl, P; Salzl, P; Trauner, M; Ferlitsch, A; Peck-Radosavljevic, M; Reiberger, T:

    Hemodynamic response to non-selective beta blockers despite lack of effects on heart rate and systemic blood pressure

  • P44
    Bota, S; Paternostro, R; Salzl, P; Mandorfer, M; Kienbacher, C; Ferlitsch, M; Reiberger, T; Trauner, M; Peck-Radosavljevic, M; Ferlitsch, A:

    Comparison between 2D-Real Time Shear Wave-Elastography (2D-SWE) and simple serological scores for liver fibrosis assessment for clinical routine, considering Transient Elastography (TE) as reference method

  • P45
    Luschnik, R:

    Diagnose Budd-Chiari-Pitfall?

  • P46
    Mandorfer, M; Bota, S; Schwabl, P; Bucsics, T; Pfisterer, N; Kruzik, M; Hagmann, M; Blacky, A; Ferlitsch, A; Sieghart, W; Trauner, M; Peck-Radosavljevic, M; Reiberger, T:

    Non-selective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis

  • P47
    Mandorfer, M; Payer, BA; Schwabl, P; Steiner, S; Ferlitsch, A; Aichelburg, MC; Stättermayer, AF; Ferenci, P; Obermayer-Pietsch, B; Grabmeier-Pfistershammer, K; Trauner, M; Peck-Radosavljevic, M; Reiberger, T:

    Revisiting Liver Disease Progression in HIV/HCV-coinfected Patients: The Influence of Vitamin D, Insulin resistance, Immune status, IL28B and PNPLA3

  • P49
    Wieser, V; Gerner, RR; Grander, C; Macheiner, S; Enrich, B; Bichler, A; Lichtmannegger, L; Moschen, AR; Tilg, H:

    Adipose tissue and liver expression of PROGRANULIN after extensive weight loss in morbid obesity

  • P50
    Payer, BA; Mandorfer, M; Schwabl, P; Scherzer, TM; Ferenci, P; Peck-Radosavljevic, M; Reiberger, T:

    Prevalence of Thrombocytopenia and course of PEGIFN-induced changes of platelet counts in special HCV populations

  • P51
    Payer, BA; Schwabl, P; Wagner, M; Garnys, L; Riedl, F; Schubert, TL; Trauner, M; Peck-Radosavljevic, M; Reiberger, T:

    The synthetic FXR agonist PX20606 attenuates bacterial translocation, intestinal inflammation, and reduces splanchnic blood flow in portal hypertensive mice

  • P52
    Voglmayr, M; Piringer, P; Rauch, M; Lenz, K:

    Fallbericht: Einsatz von Rivaroxaban (Xarelto®) bei einer 63-jährigen Patientin mit Zirrhose und Pfortaderthrombose

  • P53
    Gschwantler, M; Foster, GR; Jacobson, IM; Dore, GJ; Fried, M; Manns, M; Marcellin, P; Poordad, F; de Araujo, ES; Peeters, M; Lenz, O; Ouwerkerk-Mahadevan, S; De La Rosa, G; Kalmeijer, R; Beaumont-Mauviel, M:

    Simeprevir (TMC435) with Peginterferon/Ribavirin for treatment of chronic HCV genotype 1 infection in treatment-naïve european patients in the quest-1 and quest-2 phase III trials

  • P54
    Ferenci, P; Nyberg, A; Enayati, P; Bernstein, D; Baruch, Y; Alexandru Caruntu, F; Chulanov, V; Janczewska, E; Younes, Z; Marinho, RT; Rizzardini, G; Gervain, J; Planas, R; Moreno, C; Xie, W; Collins, C; Cohen, D; King, M; Podsadecki, T; Reddy, K:

    PEARL-III: Eine 12-wöchige Behandlung mit ABT-450/r/Ombitasvir + Dasabuvir +/- Ribavirin erreichte bei > 99% von 419 behandlungsnaiven HCV Genotyp 1b- infizierten Erwachsenen SVR

  • P55
    Illig, R; Kiesslich, T; Kemmerling, R; Alinger, B; Klieser, E; Berr, F; Neureiter, D:

    Epithelial-mesenchymal transition-associated microRNA expression pattern in human biliary tract cancer: a clinical and pathological approach

  • P56
    Steiner, S; Payer, BA; Mandorfer, M; Niederecker, A; Lang, G; Aichelburg, MC; Strassl, R; Boesecke, C; Rieger, A; Trauner, M; Peck-Radosavljevic, M; Reiberger, T:

    Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C coinfected patients in a real-world setting

  • P57
    Schwabl, P; Payer, BA; Grahovac, J; Klein, S; Boucher, Y; Trebicka, J; Angermayr, B; Fuhrmann, V; Trauner, M; Peck-Radosavljevic, M; Reiberger, T:

    Pioglitazone reduces portosystemic collateral blood flow via modulation of angiogenesis and inflammation in portal hypertensive rats

  • P58
    Schwabl, P; Bota, S; Salzl, P; Mandorfer, M; Payer, BA; Ferlitsch, A; Stift, J; Wrba, F; Trauner, M; Peck-Radosavljevic, M; Reiberger, T:

    New quality criteria for transient elastography increase valid measurements with a high accuracy for detection of liver cirrhosis and portal hypertension

  • P59
    Ortner, M; Gröchenig, HP; Siebert, F; Tscherpel, J; Korak, W:

    Kärntner Erfahrungen mit Silibinin bei HCV Genotyp 4

  • P60
    Mayr, C; Wagner, A; Stöcklinger, A; Jakab, M; Illig, R; Pichler, M; Berr, F; Neureiter, D; Kiesslich, T:

    DZNep may directly target putative cancer stem cells in biliary tract cancer cells by inhibition of PRC2

  • P61
    Ferenci, P; Forns, X; Lawitz, E; Zeuzem, S; Gane, EJ; Bronowicki, JP; Andreone, P; Horban, A; Brown, AS; Peeters, M; Lenz, O; Ouwerkerk-Mahadevan, S; De La Rosa, G; Kalmeijer, R; Beaumont-Mauviel, M:

    Simeprevir (TMC435) with Peginterferon/Ribavirin for treatment of chronic HCV genotype 1 infection in european patients who relapsed after previous interferon-based therapy: the promise trial

  • P62
    Horvath, A; Leber, B; Lemesch, S; Stiegler, P; Stauber, R; Fickert, P; Zollner, G; Spindelboeck, W; Durchschein, F; Krones, E; Douschan, P; Stadlbauer, V:

    Neutrophil dysfunction in liver cirrhosis despite sufficient opsonisation

  • P63
    Viveiros, A; Schranz, M; Finkenstedt, A; Baumgartner, N; Zoller, H; Vogel, W:

    Kontrollverlust in der Regulation der Hepcidinexpression: Klinische Implikationen der Mutationsanalyse bei Eisenstoffwechselstörungen und Identifikation von 'modifier genes'

  • P64
    Tomaschitz, P; Gröchenig, H; Asslaber, M; Siebert, F:

    Akute toxische Hepatits bei postmenopausaler Phytopharmazie

  • P65
    Finkenstedt, A; Schranz, M; Baumgartner, N; Vogel, W; Zoller, H:

    HFE Genotypen, Eisenstatus und Überleben

  • P66
    Douschan, P; Kovacs, G; Stadlbauer-Köllner, V; Spindelböck, W; Krones, E; Durchschein, F; Zollner, G; Rainer, F; Foris, V; Wagner, M; Fickert, P; Olschewski, H; Stauber, R:

    Cardiopulmonary response to exercise in patients with portal hypertension and early stages of liver cirrhosis

  • P67
    Thomas, W; Finkenstedt, A; Dorn, L; Vogel, W; Zoller, H:

    Prognostischer Wert der FENa und FEU bei Leberzirrhose mit Niereninsuffizienz

  • P68
    Schäfer, B; Glodny, B; Neureiter, D; Moser, P; Steurer, M; Dorn, L; Vogel, W; Zoller, H:

    Brentuximab Vedotin bei Post-Transplant Lymphoproliferativer Erkrankung nach Lebertransplantation

  • P69
    Wagner, L; Schrutka-Kölbl, C; Madl, C:

    Effekt von Midodrin bei Patienten mit therapierefraktärem Aszites im Rahmen einer dekompensierten Leberzirrhose auf Aszitespunktionen und Elektrolythaushalt

  • P70
    Hucke, F; Pinter, M; Graziadei, I; Vogel, W; Trauner, M; Sieghart, W; Peck-Radosavljevic, M:

    Validation of the BCLC-B subclassification in an Austrian TACE cohort

  • P71
    Hucke, F; Pinter, M; Graziadei, I; Vogel, W; Müller, C; Heinzl, H; Waneck, F; Trauner, M; Peck-Radosavljevic, M; Sieghart, W:

    How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma

  • P72
    Pachta, E; Hucke, F; Weiss, S; Popp, S; Haupt, L; Peck-Radosavljevic, M; Sieghart, W:

    Prognostic impact of the BAVENO IV staging system of portal hypertension in patients with cirrhosis and hepatocellular carcinoma

  • P73
    Horvath, A; Leber, B; Lemesch, S; Spindelboeck, W; Stiegler, P; Stadlbauer, V:

    Chronic Hepatitis C infection diminishes neutrophil function

  • P74
    Reiberger, T; Chen, B; Huang, P; Lauwers, G; Zhu, A; Jain, RK:

    HCC resistance to sorafenib can be caused by hypoxia-induced SDF1a/CXCR4 upregulation leading to tumor desmoplasia and GR1+ cell infiltration